TrialLineage Concept
Gene expression
Gene expression is the process by which information encoded in DNA is converted into functional products — typically proteins. Cells regulate which genes are expressed, when, and at what level. When this regulation fails, disease can result. Many modern therapies work by restoring, blocking, or modulating gene expression.
In plain language
What is gene expression?
Every cell in the body contains the same DNA, yet cells differ enormously — a neuron looks and functions nothing like a liver cell. The difference lies in which genes each cell expresses. Gene expression is the reading of a gene’s DNA sequence, transcription into RNA, and translation into protein.
Expression is controlled at multiple levels: which genes are accessible (chromatin state), which are transcribed (transcription factors), which mRNAs are stable (RNA processing), and which proteins are made (translation regulation). Genomic imprinting — where one parental allele is silenced — is a specific form of expression control directly relevant to Angelman syndrome.
Why gene expression matters for this case
Angelman syndrome is fundamentally a gene expression disorder. The paternal UBE3A gene is structurally intact in most patients — it is not mutated or deleted. It is silenced: an antisense RNA transcript prevents its expression in neurons. The therapy being tested (ION582) aims to alter expression by removing this silencing mechanism.
This illustrates a broader principle: not all genetic diseases require gene replacement. Some can potentially be treated by changing how existing genes are expressed — turning silent genes back on, or turning harmful genes off.
Related concepts